Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 147M | 126M |
| Research and development | 196M | 322M |
| Selling, general and administrative | 159M | 214M |
| Operating expenses | 709M | 2.31B |
| Operating income | −562M | −2.19B |
| Pre-tax income | −535M | −2.16B |
| Income tax | −126M | −135M |
| Net income | −408M | −2.03B |
| Earnings per share | −11.11 | −63.54 |
| Earnings per share, diluted | −11.11 | −63.54 |
| Weighted average shares | 37M | 32M |
| Weighted average shares, diluted | 37M | 32M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 69M | 250M | 127M | 127M | 134M | 214M | 854M | 959M |
| Receivables | 20M | 18M | 16M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −299M | −577M |
| Depreciation and amortisation | 18M | 20M |
| Share-based compensation | 58M | 86M |
| Capital expenditure | 909,000 | 5M |
| Investing cash flow | −85M | −551M |
| Financing cash flow | 423M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 16M |
| 19M |
| 20M |
| — |
| — |
| Current assets | 877M | 954M | 589M | 652M | 728M | 820M | 910M | 1.02B |
| Property, plant and equipment | 48M | 52M | 56M | 60M | 65M | 69M | — | — |
| Goodwill | — | — | — | — | — | 0 | 0 | 0 |
| Total assets | 2.80B | 2.92B | 2.60B | 2.70B | 2.85B | 2.98B | 3.12B | 3.27B |
| Current liabilities | 75M | 80M | 77M | 71M | 75M | 77M | 94M | 88M |
| Total liabilities | 303M | 344M | 361M | 388M | 434M | 480M | 530M | 575M |
| Equity | 2.50B | 2.58B | 2.24B | 2.31B | 2.41B | 2.50B | 2.59B | 2.70B |
| Shares outstanding | 41M | 40M | 36M | 36M | 35M | 34M | 33M | 0 |
| Shares issued | 41M | 40M | 36M | 36M | 35M | 34M | 33M | 0 |
| 1.24B |